Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
Standard induction therapy with lenalidomide, bortezomib, and dexamethasone did not overcome inferior outcomes in patients ...
News Medical on MSN14d
Immune environment found to influence success of leukemia immunotherapyA research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...
Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.Continued ...
Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...
Hosted on MSN14d
Researchers pinpoint keys to cell therapy response for leukemiaThe team identified that a key cell type in the DLI product and features of the tumor microenvironment in patients both ... To do this, they examined cells from the bone marrow of 25 patients with ...
More information: Tongling Huang et al, Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow, Nature Communications (2024). DOI: 10.1038/s41467-024 ...
Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...
A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback